A Prospective, Multi-Center, Randomized, Double Blind, Placebo-Controlled Trial Comparing Vitrogro® ECM To Placebo As An Adjunct To Standard Care In Patients With Venous Leg Ulcers
The objective of this study is to assess the efficacy and safety of VitroGro® combined with standard care in the treatment of Venous Leg Ulcers (VLUs) compared to Placebo with standard care over the course of the 8-week treatment phase.
100 Clinical Results associated with Tissue Therapies Europe Ltd.
0 Patents (Medical) associated with Tissue Therapies Europe Ltd.
100 Deals associated with Tissue Therapies Europe Ltd.
100 Translational Medicine associated with Tissue Therapies Europe Ltd.